title: Blocking the survival of the nastiest by HSP90 inhibition.
abstract: It is now recognised that genetic, epigenetic and phenotypic heterogeneity within individual human cancers is responsible for therapeutic resistance - knowledge that is having a profound impact on current thinking and experimentation. There has been concern that molecularly targeted therapy is doomed to failure, with resistant clones emerging in response to the Darwinian selective pressure of any drug treatment. However, two studies have shown that the evolution of drug resistance can be restrained by co-administration of a pharmacologic inhibitor of the HSP90 molecular chaperone.
authors.affiliation: Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Workman
authors.affiliation: Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Clarke
authors.affiliation: Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK.
authors.forename: Bissan
authors.initials: B
authors.lastname: Al-Lazikani
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D018841:HSP90 Heat-Shock Proteins
keywords: HSP90
references.citation: Nature. 2012 Jan 19;481(7381):306-13
references.pmid: 22258609
references.citation: Nat Biotechnol. 2012 Jul;30(7):679-92
references.pmid: 22781697
references.citation: Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18297-302
references.pmid: 25489079
references.citation: Mol Cancer Ther. 2014 Dec;13(12):2793-804
references.pmid: 25349308
references.citation: Clin Cancer Res. 2012 Jan 1;18(1):64-76
references.pmid: 22215907
references.citation: Science. 1976 Oct 1;194(4260):23-8
references.pmid: 959840
references.citation: Annu Rev Genet. 2014;48:215-36
references.pmid: 25292359